BRIEF-Teva announces FDA approval of two new RespiClick maintenance inhalers for the treatment of asthma

* Teva announces FDA approval of two new RespiClick maintenance inhalers for the treatment of asthma Source text for Eikon: Further company coverage: [Source]

Publication Date: Monday, 30 January 2017 at 15:28:58

Origin: reuters.com

Category: rbssHealthcareNews

Topics: treatment, inhalers, approval, announces, coverage, company, Further, Eikon, asthma Source, RespiClick maintenance, asthma, maintenance, RespiClick, BRIEF-Teva

Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/xTU3fVIT01Y/idUSASB0AXCL

Drugmakers look for reciprocal UK-EU regulation after Brexit

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:26:46

UPDATE 1-Opioid addiction implant maker Braeburn Pharma pulls IPO

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:10:46

BRIEF-Nestle Health Science plans to expand manufacturing facility in Eau Claire, Wi

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 17:45:15

BRIEF-Medivir says EGM backs redemption programme

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:54:21

BRIEF-Cymabay announces pricing of public offering of common stock

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:37:22

Analyzed News